Kodein Dak (Codeine Phosphate Sesquihydrate)

Codeine phosphate, the active ingredient in Kodein Dak, is an opioid analgesic presented as an oral formulation for oral use. It is employed to relieve mild to moderate pain and to suppress cough in adult patients when other treatments are insufficient. It is indicated for short‑term use under medical supervision.

GNH USA supplies Kodein Dak as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch.

Codeine phosphate acts on the central nervous system to provide analgesic and antitussive effects.

- Mild to moderate pain: provides relief by reducing the perception of pain. - Acute cough: suppresses the cough reflex in respiratory conditions. - Post‑operative discomfort: helps manage short‑term discomfort after minor surgical procedures.

Adverse reactions may occur with codeine phosphate use.

Common Side Effects: - Nausea: feeling of sickness or urge to vomit. - Constipation: reduced bowel movements and hard stools. - Drowsiness: increased sleepiness or fatigue. - Dizziness: light‑headed sensation or loss of balance. - Dry mouth: reduced salivation causing throat discomfort. - Itching: mild skin pruritus.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe allergic reaction: rash, swelling, or anaphylaxis requiring immediate medical attention. - Dependence or addiction: potential for misuse with prolonged use. - Hepatotoxicity: liver injury in rare cases.

Before prescribing Kodein Dak, clinicians should evaluate patient history and potential risk factors.

- Assess pain severity: confirm that pain is mild to moderate and suitable for an opioid. - Review respiratory status: avoid use in patients with compromised breathing. - Check for drug interactions: consider concurrent CNS depressants. - Monitor for dependence: limit duration and dosage as appropriate. - Avoid in children: not recommended for pediatric use without specialist advice. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Codeine phosphate may interact with other medicines, altering its effect or safety profile.

Major Interactions (Avoid): - Other opioids: additive respiratory depression risk. - Benzodiazepines or barbiturates: enhanced CNS depression. - Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine): may reduce analgesic conversion. - Alcohol: can increase sedation and respiratory effects. - Anticholinergics: may worsen constipation.